Session Agenda

Learning Objectives:

-Describe the prevalence, predictors, and consequences of prescription stimulant misuse and diversion in college attending and non-college attending young adults

-Explain young adults’ motivations for prescription stimulant misuse and how they typically procure these medications

-Discuss examples of brief interventions aimed at preventing prescription stimulant misuse and diversion

(1.00 credit)

Learning Objectives:

-Understand the current epidemiology of comorbidity associated with ADHD

-Appreciate the diagnostic dilemmas in evaluating comorbidity within ADHD

-List treatment strategies for individuals with ADHD who manifest comorbid psychiatric disorders

(1.25 credits)

Learning Objectives:

-Identify promising approaches to enhance access to services

-Describe the components of a continuum of care for stimulant use disorder

-Analyze barriers to service delivery and strategies to overcome them

(.50 credits)

Learning Objectives:

-The learner will be able to identify supplemental stimulant use disorder treatment modalities

-The learner will be able to conceive recovery housing as a potential upstream and sustainable solution for individuals in recovery

-The learner will be able to recognize the importance of building recovery capital in rural-residing individuals with prior  stimulant use disorder.

(.75 credits)

Learning Objectives:

-List the prevalence of methamphetamine use and methamphetamine psychosis (MAP) and the problems that it places on healthcare and social services

-Describe the effective testing and screening process for MAP

-Apply a 'best treatment' protocol for addressing MAP to current medical and clinical practice

(.75 credtis)

Learning Objectives:

-Assess processes used in identifying putative medication candidates and list promising pharmacotherapies for stimulant use disorders.

-Describe the rationale for targeting symptoms associated with stimulant use disorders.

-Provide evidence supporting recommendations of at least two future pharmacotherapy trials of medications that address symptoms common during withdrawal from stimulant use.

(.75 credits)

Learning Objectives:

-Identify the unique challenges engaging patients with stimulant use disorder into treatment

-Identify the challenges of moving patients from hospitals to treatment settings

-Evaluate the use of the SBIRT model and associated assessment tools for their use

(.75 credits)

Learning Objectives:

-Define the four key areas of focus

-Describe the population of patients presenting with stimulant use disorder

-Review evidence-based treatments for the stimulant use disorder

-Define “success” in terms of treatment outcomes

-Discuss the application of the areas of focus to the treatment of stimulant use disorders

(.75 credits)

Learning Objectives:

-Describe the issues of stimulants contaminated by or co-used with synthetic opioids and how they affect the risk environment for persons who inject drugs

-Describe recent changes in the supply of illicit stimulants in Ohio and the implications for overdose deaths

-Describe trends in polysubstance use among primary heroin injectors in West Virginia

(.75 credits)

Learning Objectives:

-Explain the factors driving the current crisis in stimulant supply shortage

-Describe recent FDA updates to prescribing guidelines for stimulants

-Identify novel stimulant and non-stimulant agents for the treatment of ADHD in adults

-Discuss tactics prescribers can employ to optimize patient outcomes when initiating treatment for ADHD in adults

(1.00 credit)